The U.S. FDA cleared 20 drugs in October 2025, up from 17 in September, 18 in August and 17 in July, bringing the year’s total to 181 approvals through the first 10 months. Two new molecular entities ...

Inhibikase will also grant underwriters a 30-day option to purchase up to about 10.3 million additional shares of its common stock at the public-offering price, minus discounts and commissions. The ...

United Therapeutics' stock surged after IPF trial results and what future pivotal trials could mean for investors. See here ...

Chronic respiratory failure is associated with earlier and greater risks of cardiovascular diseases among individuals with COPD.

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic ...

Winrevair yielded significant and meaningful clinical benefits for patients with combined post- and precapillary pulmonary ...

Today is World COPD Day, and the American Lung Association is spotlighting a free program to provide personalized, one-on-one support to people living with COPD. The Lung Health Navigator program is ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition that causes breathing difficulties by blocking ...

Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy ...

Merck on Tuesday said its drug, Winrevair, met the primary endpoint in a Phase 2 study in adults with post- and precapillary pulmonary hypertension due to heart failure. The Rahway, N.J., ...

Through healthcare worker training, community education, and practical diagnostic tools, the RACE Africa project is equipping frontline healthcare providers to recognise and manage COPD — and ...

I am a 76-year-old woman in what I thought was excellent health. On a recent coronary calcium CT scan that was ordered because of my age and slightly elevated cholesterol, an incidental finding was ...